BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27175029)

  • 1. Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia.
    Herhaus P; Habringer S; Philipp-Abbrederis K; Vag T; Gerngross C; Schottelius M; Slotta-Huspenina J; Steiger K; Altmann T; Weißer T; Steidle S; Schick M; Jacobs L; Slawska J; Müller-Thomas C; Verbeek M; Subklewe M; Peschel C; Wester HJ; Schwaiger M; Götze K; Keller U
    Haematologica; 2016 Aug; 101(8):932-40. PubMed ID: 27175029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [68Ga]Ga-Pentixafor PET/MRI for CXCR4 Imaging of Chronic Lymphocytic Leukemia: Preliminary Results.
    Mayerhoefer ME; Jaeger U; Staber P; Raderer M; Wadsak W; Pfaff S; Kornauth C; Senn D; Weber M; Wester HJ; Skrabs C; Haug A
    Invest Radiol; 2018 Jul; 53(7):403-408. PubMed ID: 29642081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokine receptor - Directed imaging and therapy.
    Buck AK; Stolzenburg A; Hänscheid H; Schirbel A; Lückerath K; Schottelius M; Wester HJ; Lapa C
    Methods; 2017 Nov; 130():63-71. PubMed ID: 28916148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual Targeting of Acute Leukemia and Supporting Niche by CXCR4-Directed Theranostics.
    Habringer S; Lapa C; Herhaus P; Schottelius M; Istvanffy R; Steiger K; Slotta-Huspenina J; Schirbel A; Hänscheid H; Kircher S; Buck AK; Götze K; Vick B; Jeremias I; Schwaiger M; Peschel C; Oostendorp R; Wester HJ; Grigoleit GU; Keller U
    Theranostics; 2018; 8(2):369-383. PubMed ID: 29290814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Li X; Yu W; Wollenweber T; Lu X; Wei Y; Beitzke D; Wadsak W; Kropf S; Wester HJ; Haug AR; Zhang X; Hacker M
    Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1616-1625. PubMed ID: 31004184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
    Lapa C; Lückerath K; Kleinlein I; Monoranu CM; Linsenmann T; Kessler AF; Rudelius M; Kropf S; Buck AK; Ernestus RI; Wester HJ; Löhr M; Herrmann K
    Theranostics; 2016; 6(3):428-34. PubMed ID: 26909116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
    Philipp-Abbrederis K; Herrmann K; Knop S; Schottelius M; Eiber M; Lückerath K; Pietschmann E; Habringer S; Gerngroß C; Franke K; Rudelius M; Schirbel A; Lapa C; Schwamborn K; Steidle S; Hartmann E; Rosenwald A; Kropf S; Beer AJ; Peschel C; Einsele H; Buck AK; Schwaiger M; Götze K; Wester HJ; Keller U
    EMBO Mol Med; 2015 Apr; 7(4):477-87. PubMed ID: 25736399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging.
    Wester HJ; Keller U; Schottelius M; Beer A; Philipp-Abbrederis K; Hoffmann F; Šimeček J; Gerngross C; Lassmann M; Herrmann K; Pellegata N; Rudelius M; Kessler H; Schwaiger M
    Theranostics; 2015; 5(6):618-30. PubMed ID: 25825601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid Cancers.
    Vag T; Gerngross C; Herhaus P; Eiber M; Philipp-Abbrederis K; Graner FP; Ettl J; Keller U; Wester HJ; Schwaiger M
    J Nucl Med; 2016 May; 57(5):741-6. PubMed ID: 26769866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Imaging of the Chemokine Receptor CXCR4 After Acute Myocardial Infarction.
    Thackeray JT; Derlin T; Haghikia A; Napp LC; Wang Y; Ross TL; Schäfer A; Tillmanns J; Wester HJ; Wollert KC; Bauersachs J; Bengel FM
    JACC Cardiovasc Imaging; 2015 Dec; 8(12):1417-1426. PubMed ID: 26577262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Amor-Coarasa A; Kelly JM; Singh PK; Ponnala S; Nikolopoulou A; Williams C; Vedvyas Y; Jin MM; Warren JD; Babich JW
    Molecules; 2019 Apr; 24(8):. PubMed ID: 31022852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentixafor PET/CT for imaging of chemokine receptor 4 expression in esophageal cancer - a first clinical approach.
    Linde P; Baues C; Wegen S; Trommer M; Quaas A; Rosenbrock J; Celik E; Marnitz S; Bruns CJ; Fischer T; Schomaecker K; Wester HJ; Drzezga A; van Heek L; Kobe C
    Cancer Imaging; 2021 Feb; 21(1):22. PubMed ID: 33579381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma.
    Heinze B; Fuss CT; Mulatero P; Beuschlein F; Reincke M; Mustafa M; Schirbel A; Deutschbein T; Williams TA; Rhayem Y; Quinkler M; Rayes N; Monticone S; Wild V; Gomez-Sanchez CE; Reis AC; Petersenn S; Wester HJ; Kropf S; Fassnacht M; Lang K; Herrmann K; Buck AK; Bluemel C; Hahner S
    Hypertension; 2018 Feb; 71(2):317-325. PubMed ID: 29279316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging the Cytokine Receptor CXCR4 in Atherosclerotic Plaques with the Radiotracer
    Hyafil F; Pelisek J; Laitinen I; Schottelius M; Mohring M; Döring Y; van der Vorst EP; Kallmayer M; Steiger K; Poschenrieder A; Notni J; Fischer J; Baumgartner C; Rischpler C; Nekolla SG; Weber C; Eckstein HH; Wester HJ; Schwaiger M
    J Nucl Med; 2017 Mar; 58(3):499-506. PubMed ID: 27789718
    [No Abstract]   [Full Text] [Related]  

  • 15. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
    Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K
    Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Screening, and Evaluation of Theranostic Molecular CPCR4-Based Probe Targeting CXCR4.
    Yang T; Shi D; Lin Q; Shen H; Tan H; Liu Y; Shi H; Cheng D
    Mol Pharm; 2024 May; 21(5):2415-2424. PubMed ID: 38606663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4 Signaling Has a CXCL12-Independent Essential Role in Murine MLL-AF9-Driven Acute Myeloid Leukemia.
    Ramakrishnan R; Peña-Martínez P; Agarwal P; Rodriguez-Zabala M; Chapellier M; Högberg C; Eriksson M; Yudovich D; Shah M; Ehinger M; Nilsson B; Larsson J; Hagström-Andersson A; Ebert BL; Bhatia R; Järås M
    Cell Rep; 2020 May; 31(8):107684. PubMed ID: 32460032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting primary acute myeloid leukemia with a new CXCR4 antagonist IgG1 antibody (PF-06747143).
    Zhang Y; Saavedra E; Tang R; Gu Y; Lappin P; Trajkovic D; Liu SH; Smeal T; Fantin V; De Botton S; Legrand O; Delhommeau F; Pernasetti F; Louache F
    Sci Rep; 2017 Aug; 7(1):7305. PubMed ID: 28779088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating MRI and Chemokine Receptor CXCR4-Targeted PET for Detection of Leukocyte Infiltration in Complicated Urinary Tract Infections After Kidney Transplantation.
    Derlin T; Gueler F; Bräsen JH; Schmitz J; Hartung D; Herrmann TR; Ross TL; Wacker F; Wester HJ; Hiss M; Haller H; Bengel FM; Hueper K
    J Nucl Med; 2017 Nov; 58(11):1831-1837. PubMed ID: 28450555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [
    Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
    Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.